Variant report

Variant	nsv892660
Chromosome Location	chr9:17134245-17269437
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr9:17137735-17137782	HepG2	liver:	n/a	n/a
2	ARID3A	chr9:17138550-17138914	HepG2	liver:	n/a	n/a
3	ARID3A	chr9:17171685-17171982	HepG2	liver:	n/a	n/a
4	BACH1	chr9:17134393-17135230	H1-hESC	embryonic stem cell:	n/a	n/a
5	BCL3	chr9:17134706-17135204	A549	lung:	n/a	n/a
6	BRCA1	chr9:17134759-17135091	H1-hESC	embryonic stem cell:	n/a	n/a
7	BRCA1	chr9:17135427-17135902	Hela-S3	cervix:	n/a	n/a
8	BRCA1	chr9:17134617-17135090	Hela-S3	cervix:	n/a	n/a
9	CEBPB	chr9:17166457-17166705	A549	lung:	n/a	chr9:17166540-17166551
10	CEBPB	chr9:17171651-17172080	HepG2	liver:	n/a	n/a
11	CEBPB	chr9:17167580-17167863	IMR90	lung:	n/a	chr9:17167704-17167715
12	CEBPB	chr9:17167623-17167870	HepG2	liver:	n/a	chr9:17167704-17167715
13	CEBPB	chr9:17180075-17180119	H1-hESC	embryonic stem cell:	n/a	chr9:17180087-17180098
14	CEBPB	chr9:17134697-17135085	H1-hESC	embryonic stem cell:	n/a	n/a
15	CEBPB	chr9:17180013-17180198	IMR90	lung:	n/a	chr9:17180087-17180098
16	CEBPB	chr9:17166392-17166714	HepG2	liver:	n/a	chr9:17166540-17166551
17	CEBPB	chr9:17138347-17138844	HepG2	liver:	n/a	n/a
18	CEBPB	chr9:17179998-17180190	HepG2	liver:	n/a	chr9:17180087-17180098
19	CEBPB	chr9:17134379-17135487	Hela-S3	cervix:	n/a	n/a
20	CHD1	chr9:17134912-17135269	H1-hESC	embryonic stem cell:	n/a	n/a
21	CHD1	chr9:17135529-17135877	H1-hESC	embryonic stem cell:	n/a	n/a
22	CHD2	chr9:17134500-17135713	Hela-S3	cervix:	n/a	chr9:17135487-17135494
23	CHD2	chr9:17134712-17135767	H1-hESC	embryonic stem cell:	n/a	chr9:17135487-17135494
24	CHD2	chr9:17134742-17135165	HepG2	liver:	n/a	n/a
25	CREB1	chr9:17134740-17135001	A549	lung:	n/a	n/a
26	CTBP2	chr9:17134341-17135818	H1-hESC	embryonic stem cell:	n/a	n/a
27	CTCF	chr9:17219320-17219470	HCM	heart:	n/a	chr9:17219448-17219464 chr9:17219450-17219459 chr9:17219447-17219465 chr9:17219450-17219463 chr9:17219449-17219470
28	CTCF	chr9:17219340-17219490	HVMF	connective:	n/a	chr9:17219448-17219464 chr9:17219450-17219459 chr9:17219447-17219465 chr9:17219450-17219463 chr9:17219449-17219470
29	CTCF	chr9:17219380-17219530	HRPEpiC	eye:	n/a	chr9:17219448-17219464 chr9:17219450-17219459 chr9:17219447-17219465 chr9:17219450-17219463 chr9:17219449-17219470
30	CTCF	chr9:17135056-17135137	ProgFib	skin:	n/a	n/a
31	CTCF	chr9:17256789-17256845	GM13976	blood:	n/a	n/a
32	CTCF	chr9:17219360-17219510	HCFaa	heart:	n/a	chr9:17219448-17219464 chr9:17219450-17219459 chr9:17219447-17219465 chr9:17219450-17219463 chr9:17219449-17219470
33	CTCF	chr9:17135420-17135570	HBMEC	blood vessel:	n/a	n/a
34	CTCF	chr9:17219350-17219540	LNCaP	prostate:	n/a	chr9:17219448-17219464 chr9:17219450-17219459 chr9:17219447-17219465 chr9:17219450-17219463 chr9:17219449-17219470
35	CTCF	chr9:17136920-17137070	GM12864	blood:	n/a	n/a
36	CTCF	chr9:17219238-17219671	MCF-7	breast:	n/a	chr9:17219448-17219464 chr9:17219450-17219459 chr9:17219447-17219465 chr9:17219450-17219463 chr9:17219449-17219470
37	CTCF	chr9:17135481-17135550	GM19240	blood:	n/a	n/a
38	CTCF	chr9:17259629-17259709	GM10248	blood:	n/a	n/a
39	CTCF	chr9:17135482-17135503	GM12892	blood:	n/a	n/a
40	CTCF	chr9:17219340-17219490	AG04450	lung:	n/a	chr9:17219448-17219464 chr9:17219450-17219459 chr9:17219447-17219465 chr9:17219450-17219463 chr9:17219449-17219470
41	CTCF	chr9:17219400-17219550	HCPEpiC	choroid plexus:	n/a	chr9:17219448-17219464 chr9:17219450-17219459 chr9:17219447-17219465 chr9:17219450-17219463 chr9:17219449-17219470
42	CTCF	chr9:17135476-17135493	Fibrobl	skin:	n/a	n/a
43	CTCF	chr9:17200640-17200790	Hela-S3	cervix:	n/a	n/a
44	CTCF	chr9:17219360-17219510	Caco-2	colon:	n/a	chr9:17219448-17219464 chr9:17219450-17219459 chr9:17219447-17219465 chr9:17219450-17219463 chr9:17219449-17219470
45	CTCF	chr9:17135420-17135570	HUVEC	blood vessel:	n/a	n/a
46	CTCF	chr9:17135560-17135710	GM12864	blood:	n/a	n/a
47	CTCF	chr9:17219380-17219530	HMEC	breast:	n/a	chr9:17219448-17219464 chr9:17219450-17219459 chr9:17219447-17219465 chr9:17219450-17219463 chr9:17219449-17219470
48	CTCF	chr9:17219380-17219530	HCT-116	colon:	n/a	chr9:17219448-17219464 chr9:17219450-17219459 chr9:17219447-17219465 chr9:17219450-17219463 chr9:17219449-17219470
49	CTCF	chr9:17135540-17135690	SAEC	small airway:	n/a	n/a
50	CTCF	chr9:17219400-17219550	HRPEpiC	eye:	n/a	chr9:17219448-17219464 chr9:17219450-17219459 chr9:17219447-17219465 chr9:17219450-17219463 chr9:17219449-17219470

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:17134842-17134892	HIPEpiC	eye:	n/a
2	chr9:17134842-17134892	ProgFib	skin:	n/a
3	chr9:17134842-17134892	HRPEpiC	eye:	n/a
4	chr9:17134842-17134892	GM12891	blood:	n/a
5	chr9:17135705-17135755	PANC-1	pancreas:	n/a
6	chr9:17137020-17137070	LNCaP	prostate:	n/a
7	chr9:17134569-17134619	H1-hESC	embryonic stem cell:	embryo
8	chr9:17137020-17137070	NHBE	bronchial:	n/a
9	chr9:17135705-17135755	HCPEpiC	choroid plexus:	n/a
10	chr9:17134842-17134892	NB4	blood:	n/a
11	chr9:17135705-17135755	RPTEC	kidney:	n/a
12	chr9:17135705-17135755	AG04450	lung:	fetal
13	chr9:17135705-17135755	HCT-116	colon:	n/a
14	chr9:17137020-17137070	HL-60	blood:	n/a
15	chr9:17134842-17134892	AoSMC	blood vessel:	n/a
16	chr9:17135705-17135755	GM12892	blood:	n/a
17	chr9:17134842-17134892	MCF10A-Er-Src	breast:	n/a
18	chr9:17134842-17134892	Jurkat	blood:	n/a
19	chr9:17135705-17135755	HMEC	breast:	n/a
20	chr9:17134842-17134892	SK-N-SH_RA	brain:	n/a
21	chr9:17137020-17137070	HUVEC	blood vessel:	n/a
22	chr9:17137020-17137070	CMK	blood:	n/a
23	chr9:17134569-17134619	SK-N-SH_RA	brain:	n/a
24	chr9:17135705-17135755	SKMC	muscle:	n/a
25	chr9:17135705-17135755	HAEpiC	amniotic membrane:	n/a
26	chr9:17135705-17135755	U87	brain:	n/a
27	chr9:17134569-17134619	GM19239	blood:	n/a
28	chr9:17135705-17135755	GM19239	blood:	n/a
29	chr9:17135705-17135755	HepG2	liver:	n/a
30	chr9:17135705-17135755	GM12891	blood:	n/a
31	chr9:17134569-17134619	MCF-7	breast:	n/a
32	chr9:17134569-17134619	HNPCEpiC	eye:	n/a
33	chr9:17134569-17134619	T-47D	breast:	n/a
34	chr9:17134842-17134892	ECC-1	luminal epithelium:	n/a
35	chr9:17135705-17135755	T-47D	breast:	n/a
36	chr9:17137020-17137070	HEEpiC	esophagus:	n/a
37	chr9:17135705-17135755	SAEC	small airway:	n/a
38	chr9:17134842-17134892	A549	lung:	n/a
39	chr9:17134842-17134892	ovcar-3	ovarian:	n/a
40	chr9:17134842-17134892	HMEC	breast:	n/a
41	chr9:17137020-17137070	ovcar-3	ovarian:	n/a
42	chr9:17135705-17135755	HRE	kidney:	n/a
43	chr9:17135705-17135755	LNCaP	prostate:	n/a
44	chr9:17135705-17135755	AG04449	skin:	fetal
45	chr9:17137020-17137070	AoSMC	blood vessel:	n/a
46	chr9:17134569-17134619	AoSMC	blood vessel:	n/a
47	chr9:17135705-17135755	NHDF-neo	bronchial:	n/a
48	chr9:17134569-17134619	AG10803	skin:	n/a
49	chr9:17134569-17134619	BE2_C	brain:	n/a
50	chr9:17135705-17135755	AG09309	skin:	n/a

No.	Distal block	Cell Line	Cell type
1	chr17:59651978..59652576-chr9:17247861..17248361,2	MCF-7	breast:
2	chr5:43121428..43122109-chr9:17134722..17135406,2	Hela-S3	cervix:
3	chr13:49549584..49550165-chr9:17134587..17135235,2	NB4	blood:
4	chr15:23810837..23811461-chr9:17134816..17135417,2	NB4	blood:
5	chr1:11969364..11970234-chr9:17134620..17135236,2	Hela-S3	cervix:
6	chr9:17219155..17220052-chr9:17401883..17402825,5	MCF-7	breast:
7	chr9:17219375..17219930-chr9:17402045..17403347,3	MCF-7	breast:
8	chr9:17219048..17219921-chr9:17462587..17463121,2	MCF-7	breast:
9	chr6:692813..693544-chr9:17134998..17135501,2	NB4	blood:

Variant related genes	Relation type
CNTLN	TF binding region
CNTLN	CpG island
ENSG00000172262	chromatin interactions
ENSG00000179455	chromatin interactions
ENSG00000112685	chromatin interactions
ENSG00000201801	chromatin interactions
ENSG00000102531	chromatin interactions

Extended variants
information (count: 6572 )
Associated
traits (count: 87 )

Variant overlapped rSNPs/rCNVs (count:6572 , 50 per page) page: 1 2 3 4 5 6 7 ... 132

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4493995	chr9:17134245-17134246	Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs4481710	chr9:17134263-17134264	Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs558953143	chr9:17134271-17134272	Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs577451868	chr9:17134314-17134315	Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs147673759	chr9:17134318-17134319	Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs553529296	chr9:17134351-17134352	Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs114943410	chr9:17134374-17134375	Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs1888326	chr9:17134391-17134392	Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs563678368	chr9:17134394-17134395	Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs149741735	chr9:17134396-17134397	Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs116115743	chr9:17134397-17134398	Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs558427092	chr9:17134398-17134399	Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs145651967	chr9:17134438-17134439	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs368729174	chr9:17134440-17134441	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs547318468	chr9:17134449-17134450	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs565857887	chr9:17134471-17134472	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs529748219	chr9:17134526-17134527	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs185852877	chr9:17134560-17134561	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs569330346	chr9:17134561-17134562	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs536683980	chr9:17134602-17134603	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs558505010	chr9:17134604-17134605	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs571104379	chr9:17134631-17134632	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs535318731	chr9:17134635-17134636	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs148875275	chr9:17134648-17134649	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs372656814	chr9:17134651-17134652	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs575042561	chr9:17134710-17134711	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs542366745	chr9:17134742-17134743	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
28	rs143570970	chr9:17134796-17134797	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
29	rs575791249	chr9:17134815-17134816	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
30	rs137913152	chr9:17134843-17134844	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
31	rs564500148	chr9:17134889-17134890	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
32	rs140906458	chr9:17134890-17134891	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
33	rs144584987	chr9:17134903-17134904	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
34	rs569738313	chr9:17134920-17134921	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
35	rs114866763	chr9:17134939-17134940	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
36	rs368815458	chr9:17134952-17134953	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
37	rs577219559	chr9:17134971-17134972	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
38	rs189166495	chr9:17134973-17134974	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
39	rs530628237	chr9:17135008-17135009	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
40	rs112166522	chr9:17135015-17135016	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
41	rs551926108	chr9:17135035-17135036	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
42	rs554253415	chr9:17135039-17135040	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
43	rs570389433	chr9:17135082-17135083	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
44	rs377494800	chr9:17135093-17135094	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
45	rs369582609	chr9:17135108-17135109	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
46	rs200585959	chr9:17135111-17135112	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
47	rs41306071	chr9:17135115-17135116	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs199753962	chr9:17135133-17135134	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
49	rs371043226	chr9:17135137-17135138	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
50	rs201309700	chr9:17135162-17135163	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:87)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Myelofibrosis	22110671	CNVD
Glycine encephalopathy	21572526	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Glioblastoma multiforme	18628472	CNVD
Breast cancer	21364760	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:1165 , 50 per page) page: 1 2 3 4 5 6 7 ... 24

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:17131200-17134400	Weak transcription	Primary monocytes fromperipheralblood	blood
2	chr9:17131200-17134400	Weak transcription	Primary neutrophils fromperipheralblood	blood
3	chr9:17131200-17134400	Weak transcription	Monocytes-CD14+_RO01746	blood
4	chr9:17131800-17134400	Weak transcription	A549	lung
5	chr9:17132600-17134400	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
6	chr9:17133600-17134600	Enhancers	Liver	Liver
7	chr9:17133800-17134600	Enhancers	Fetal Stomach	stomach
8	chr9:17134000-17134400	Enhancers	Breast Myoepithelial Primary Cells	Breast
9	chr9:17134000-17134400	Enhancers	Colon Smooth Muscle	Colon
10	chr9:17134200-17134400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
11	chr9:17134200-17134400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
12	chr9:17134200-17134400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
13	chr9:17134200-17134400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
14	chr9:17134200-17134400	Enhancers	Adipose Nuclei	Adipose
15	chr9:17134200-17134400	Enhancers	Brain Angular Gyrus	brain
16	chr9:17134200-17134400	Enhancers	Brain Cingulate Gyrus	brain
17	chr9:17134200-17134400	Enhancers	Brain Inferior Temporal Lobe	brain
18	chr9:17134200-17134400	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
19	chr9:17134200-17134400	Enhancers	Duodenum Mucosa	Duodenum
20	chr9:17134200-17134400	Enhancers	Duodenum Smooth Muscle	Duodenum
21	chr9:17134200-17134400	Enhancers	Fetal Brain Male	brain
22	chr9:17134200-17134400	Enhancers	Fetal Heart	heart
23	chr9:17134200-17134400	Enhancers	Fetal Kidney	kidney
24	chr9:17134200-17134400	Enhancers	Fetal Lung	lung
25	chr9:17134200-17134400	Enhancers	Ovary	ovary
26	chr9:17134200-17134400	Enhancers	Rectal Smooth Muscle	rectum
27	chr9:17134200-17134400	Enhancers	Skeletal Muscle Male	skeletal muscle
28	chr9:17134200-17134400	Enhancers	Stomach Smooth Muscle	stomach
29	chr9:17134200-17134400	Enhancers	Dnd41	blood
30	chr9:17134200-17134400	Enhancers	Hela-S3	cervix
31	chr9:17134200-17134400	Enhancers	NHLF	lung
32	chr9:17134200-17134400	Enhancers	Osteobl	bone
33	chr9:17134200-17134600	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
34	chr9:17134200-17134600	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
35	chr9:17134200-17134600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
36	chr9:17134200-17134600	Enhancers	Brain Germinal Matrix	brain
37	chr9:17134200-17134600	Enhancers	Fetal Intestine Large	intestine
38	chr9:17134200-17134600	Enhancers	Fetal Intestine Small	intestine
39	chr9:17134200-17134600	Enhancers	Fetal Muscle Leg	muscle
40	chr9:17134200-17136400	Active TSS	Fetal Brain Female	brain
41	chr9:17134400-17134600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
42	chr9:17134400-17134600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
43	chr9:17134400-17134600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
44	chr9:17134400-17134600	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
45	chr9:17134400-17134600	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
46	chr9:17134400-17134600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
47	chr9:17134400-17134600	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
48	chr9:17134400-17134600	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
49	chr9:17134400-17134600	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
50	chr9:17134400-17134600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links